EG 427 is a French biotechnology company specializing in gene therapy. It pioneers 'pinpoint gene therapy', focusing on HSV-1-based vectors to treat severe, chronic, and localized diseases, with an initial focus on neurogenic bladder disorders resulting from spinal cord injuries.
Ayming
Acquisition in 2025 
Founded in 1986, Ayming is a Paris-based management consulting firm specializing in operational efficiency. It offers services including innovation management, supply chain optimization, fixed asset management, and tax optimization, serving industries such as agri-food, retail, banking, healthcare, aerospace, and automobile.
ENYO Pharma
Series C in 2024 
ENYO Pharma is a clinical-stage biopharmaceutical company headquartered in Lyon, France, with additional operations in Melbourne, Australia. Founded in 2014, it focuses on discovering and developing antiviral therapies by studying virus-host interactions within the human protein interaction network and leveraging its drug discovery platform to identify intracellular targets and molecules. The company's pipeline includes EYP001, a lead compound that modulates FXR, aiming to reduce the hepatitis B virus cccDNA reservoir and suppress viral transcription, and EYP002 for preclinical development. It also conducts toxicology testing for antiviral candidates against multiple viruses, including influenza, and pursues additional programs aimed at chronic hepatitis B and other infectious diseases. ENYO collaborates with researchers and institutions in Lyon, including Inserm and related biopole ecosystems, to advance its programs through early-stage clinical development and preclinical studies. The company aims to translate virus-host interaction biology into therapeutics for infectious diseases and related liver and metabolic conditions.
Andera Partners
Series A in 2023 
Andera Partners is a Paris-based private equity firm founded in 2001 that invests in unlisted companies in France and internationally. The firm focuses on growth-stage opportunities, primarily through buyouts, and manages over €2 billion in investments across life sciences, growth capital, and sponsorless mezzanine debt. It targets sectors including sustainable energy, transportation and logistics, agribusiness, business-to-business and business-to-consumer, building and construction, cosmetics, distribution, industry, information technology and software, media, medical technology, real estate, therapeutic products, and tourism.
HR Path
Private Equity Round in 2022 
HR Path is a global consultancy focused on human capital management, with a team of over 500 consultants operating across North America, Europe, and the Middle East. The company specializes in HR Systems Integration, HR Outsourcing, and HR Business Consulting, offering a range of services to support businesses in their digital transformation. HR Path is an authorized reseller of various HR software solutions, including those from SAP, SuccessFactors, and Oracle HCM, among others. In addition to reselling, the company has developed its own HR software solutions, such as BiHRdy, a business intelligence tool; Pandore, a packaged HR, payroll, and time management solution; and Geef, a talent management system. The client portfolio includes a mix of large corporations, including CAC 40-listed companies, as well as small and medium-sized enterprises and public sector organizations, reflecting its versatility in meeting diverse client needs.
Lhyfe
Venture Round in 2022 
Lhyfe is a French company founded in 2017 and based in Nantes, specializing in the design, development, and operation of industrial sites for the production of green hydrogen derived from renewable energy sources such as wind and solar power. The company focuses on creating sustainable and flexible production facilities that provide substantial quantities of clean hydrogen, aimed at facilitating the transition of various industrial sectors and transportation to a clean energy framework. Lhyfe targets two primary markets: heavy mobility, which includes trucks, buses, trains, and potentially maritime and air transport in the future, and industrial sectors such as chemistry, steel, and glass production, which are significant contributors to greenhouse gas emissions. By ensuring minimal environmental impact, Lhyfe is committed to delivering affordable green hydrogen to support a sustainable energy transition.
Atlantic Therapeutics Limited
Venture Round in 2021 
Atlantic Therapeutics Limited is a medical technology company based in Galway, Ireland, with additional offices in London, Paris, and Salem. Established in 2013, the company specializes in the manufacture and distribution of medical devices designed for pelvic floor muscle strengthening and nerve stimulation. Its key products include Innovotherapy, a device aimed at enhancing pelvic floor muscle function, and INNOVO, a wearable device specifically targeting stress urinary incontinence by addressing its underlying causes. Atlantic Therapeutics distributes its products through a network of distributors across Ireland, the United Kingdom, France, Germany, and the Middle East. The company operates as a subsidiary of Bio-Medical Research Limited.
Medlumics
Venture Round in 2021 
Founded in 2009, Medlumics designs and manufactures catheter-based systems for treating supraventricular tachycardias. Utilizing optical coherence tomography technology, the company's products provide real-time, sectional information about tissue, enhancing procedural safety and efficacy.
Sogetrel
Acquisition in 2021 
Sogetrel, S.A.S. is a prominent company specializing in the design, deployment, and maintenance of network infrastructures and digital communication solutions. Established in 1985 and headquartered in Issy les Moulineaux, France, Sogetrel operates branches in Belgium and Switzerland. The company provides a range of services, including the integration of telecommunications networks, IP security systems for video surveillance and access control, and support for smart city projects. Sogetrel serves a diverse clientele across various sectors such as telecommunications, public authorities, defense, transport, and utilities. By focusing on the development of very high-speed networks and offering both customized and turnkey solutions, Sogetrel aims to enhance the quality of life for citizens while promoting efficiency and sustainability in the regions it serves.
Sirsa
Venture Round in 2021 
Sirsa, established in 2014 and based in Paris, France, is a consulting firm focused on sustainable transformation. The company specializes in evaluating existing processes and analyzing risks to define strategies for transforming operations. Sirsa offers a comprehensive suite of services that includes implementing strategic plans, managing action plans, reporting results, and providing compliance services. The firm caters to a diverse range of industries, including aerospace, defense, food products, electrical equipment, healthcare, energy, medical supplies, environmental, and software sectors. In addition, Sirsa has developed a software-as-a-service (SAAS) platform that measures companies' extra-financial footprint and impacts, further enhancing its commitment to sustainability and operational effectiveness.
MasterGrid
Private Equity Round in 2019 
MasterGrid specializes in manufacturing high voltage electrical equipment tailored for commercial and industrial sectors. Established in Grenoble, France, the company offers a range of products including distribution, protection, control, and management solutions.
Olaqin
Acquisition in 2019 
Olaqin is an e-health service provider that caters to healthcare professionals through a value-added distribution network for SESAM-Vitale readers and associated software, as well as through public contracts with hospitals and service contracts with pharmacies.
Ellisphere
Acquisition in 2019 
Ellisphere is a business intelligence company that provides decision-making information to executives and decision-makers in France and internationally through its BIGnet network. The company offers a comprehensive platform that delivers economic and financial information about trading partners, as well as insights into customer and supplier portfolios. Additionally, it provides guidance on legislation and regulatory compliance, helping businesses to develop effective customer-base strategies. By focusing on information management and data marketing, Ellisphere supports organizations in promoting and sustaining their growth and development.
HR Path
Private Equity Round in 2019 
HR Path is a global consultancy focused on human capital management, with a team of over 500 consultants operating across North America, Europe, and the Middle East. The company specializes in HR Systems Integration, HR Outsourcing, and HR Business Consulting, offering a range of services to support businesses in their digital transformation. HR Path is an authorized reseller of various HR software solutions, including those from SAP, SuccessFactors, and Oracle HCM, among others. In addition to reselling, the company has developed its own HR software solutions, such as BiHRdy, a business intelligence tool; Pandore, a packaged HR, payroll, and time management solution; and Geef, a talent management system. The client portfolio includes a mix of large corporations, including CAC 40-listed companies, as well as small and medium-sized enterprises and public sector organizations, reflecting its versatility in meeting diverse client needs.
Tournus Equipement
Private Equity Round in 2019 
Tournus Equipement, S.A.S. is a manufacturer based in Tournus, France, specializing in stainless steel environments for professional kitchens and supermarket fish counters. Established in 1910, the company provides a wide range of products, including mobile and modular professional kitchens, regeneration ovens, warmers, sterilizing cabinets, dishwashing equipment, and various stainless steel furniture and shelving solutions. Its offerings also encompass self-service lines for meal distribution, custom equipment, and accessories such as wash-basins, gutters, floor drains, trolleys, and containers. Tournus Equipement serves diverse sectors, including canteens in companies and schools, restaurants, hotels, bakeries, supermarkets, and transport catering services. The company is committed to delivering durable and customizable solutions tailored to meet the specific needs of its clients.
Verbraeken Infra
Acquisition in 2019 
Verbraeken Infra NV is a Belgian company specializing in the construction and renovation of underground and overhead infrastructure networks across Europe and North Africa. Founded in 1966 and based in Temse, Belgium, the company provides a wide range of services, including earth and roadworks, pipeline and sewer installation, and electrical works such as the installation of underground transmission cables and public lighting maintenance. Verbraeken Infra also engages in the installation of traditional copper and coaxial cables, as well as advanced techniques like horizontal directional drilling and pipe jacking. With approximately 1,000 employees and annual sales of €140 million, the company has expanded its operations in France, Germany, and the Benelux region, strengthening its market position in Belgium and enhancing its capacity to serve gas, water, electricity, and telecom companies.
Atlantic Therapeutics Limited
Series B in 2019 
Atlantic Therapeutics Limited is a medical technology company based in Galway, Ireland, with additional offices in London, Paris, and Salem. Established in 2013, the company specializes in the manufacture and distribution of medical devices designed for pelvic floor muscle strengthening and nerve stimulation. Its key products include Innovotherapy, a device aimed at enhancing pelvic floor muscle function, and INNOVO, a wearable device specifically targeting stress urinary incontinence by addressing its underlying causes. Atlantic Therapeutics distributes its products through a network of distributors across Ireland, the United Kingdom, France, Germany, and the Middle East. The company operates as a subsidiary of Bio-Medical Research Limited.
The Bioclinic Group
Private Equity Round in 2018 
Bioclinic operates a network of medical analysis laboratories in the Ile-de-France region, serving health professionals, hospitals, clinics, care centers, and retirement homes. Founded in 1995 and based in Paris, the company specializes in areas such as molecular biology, genetics, antibiotic resistance, and reproductive health. By focusing on these fields, Bioclinic aims to provide clients and their patients with enhanced medical diagnostic results.
Atlantic Therapeutics Limited
Private Equity Round in 2018 
Atlantic Therapeutics Limited is a medical technology company based in Galway, Ireland, with additional offices in London, Paris, and Salem. Established in 2013, the company specializes in the manufacture and distribution of medical devices designed for pelvic floor muscle strengthening and nerve stimulation. Its key products include Innovotherapy, a device aimed at enhancing pelvic floor muscle function, and INNOVO, a wearable device specifically targeting stress urinary incontinence by addressing its underlying causes. Atlantic Therapeutics distributes its products through a network of distributors across Ireland, the United Kingdom, France, Germany, and the Middle East. The company operates as a subsidiary of Bio-Medical Research Limited.
Skill and You
Acquisition in 2018 
Skill and You is France's leading vocational e-learning provider, committed to innovation and professionalism. It offers effective online learning solutions, delivering recognized qualifications (BAC PRO, BEP, BP, BTS, CAP) through adaptive education technology.
ENYO Pharma
Series B in 2018 
ENYO Pharma is a clinical-stage biopharmaceutical company headquartered in Lyon, France, with additional operations in Melbourne, Australia. Founded in 2014, it focuses on discovering and developing antiviral therapies by studying virus-host interactions within the human protein interaction network and leveraging its drug discovery platform to identify intracellular targets and molecules. The company's pipeline includes EYP001, a lead compound that modulates FXR, aiming to reduce the hepatitis B virus cccDNA reservoir and suppress viral transcription, and EYP002 for preclinical development. It also conducts toxicology testing for antiviral candidates against multiple viruses, including influenza, and pursues additional programs aimed at chronic hepatitis B and other infectious diseases. ENYO collaborates with researchers and institutions in Lyon, including Inserm and related biopole ecosystems, to advance its programs through early-stage clinical development and preclinical studies. The company aims to translate virus-host interaction biology into therapeutics for infectious diseases and related liver and metabolic conditions.
Biogroup-LCD
Debt Financing in 2018 
BIOGROUP-LCD, a major French player in local medical biology, supports more than 20,000 patients every day and offers more than 2000 routine and specialized daily examinations, based on performance and technological innovation. Partner at every moment between the patient and the medical profession, your laboratory participates in the screening, diagnosis, monitoring and prognosis of the most common pathologies to the most demanding, throughout your course of care. BIOGROUP-LCD develops for this purpose all its human and technological resources. The team of qualified, qualified medical biologists follows continuous and regular training.
TimeOne
Acquisition in 2017 
TimeOne, established in 2016, is a global marketing services group formed by merging Public-Idées and Place des Leads. Headquartered in France with operations across Europe, Asia, South Africa, and South America, the company specializes in providing comprehensive digital marketing solutions. TimeOne's core offerings include programmatic advertising, native content marketing, performance-based campaigns, digital marketplace management, publishing services, and mobile marketing strategies. The company is renowned for its innovative approach to prescriptive marketing, driven by a robust data management platform (DMP) and a strong focus on research and development.
Globe Groupe
Private Equity Round in 2017 
GLOBE Groupe sa is a Paris-based advertising agency that specializes in strategic marketing and communication services. The company focuses on shopper marketing to create impactful consumer experiences that drive sales. It offers a range of services including strategic planning, non-media planning, talent casting, recruitment, training, payroll, and logistics such as storage, dispatch, and cold-chain management. GLOBE Groupe also implements marketing activation campaigns and provides tools for performance measurement, utilizing key performance indicators to assess the effectiveness of its strategies. The firm caters to various sectors including consumer goods, media, retail, and recruitment, ensuring that its clients can adapt to the evolving landscape of consumer behavior and promotional messaging. Through its secure online platform, myGLOBE, clients can monitor operations in real-time, enhancing transparency and communication throughout the marketing process.
Intech
Private Equity Round in 2017 
Intech is a leading manufacturer of orthopedic instruments and implants dedicated to enhancing patient outcomes. Operating with a workforce of around 1,000 employees globally, the company provides comprehensive manufacturing solutions to medical device original equipment manufacturers (OEMs). Intech specializes in a wide range of surgical tools, including implants, sterilization cases, and trays, catering to various medical fields such as spine, hip, knee, sports medicine, and trauma surgery. With facilities located in the United States, France, and Malaysia, Intech is positioned as a one-stop shop for medical device OEMs, delivering both off-the-shelf and custom-made instruments efficiently and cost-effectively.
Groupe 3S
Private Equity Round in 2017 
Founded in 2001, Groupe 3S specializes in ground handling services for airlines and airport managers. It offers a range of services including passenger and baggage handling, aircraft de-icing, cleaning, and security training courses. The company has grown to become one of the world's leading providers in its sector.
Klaxcar
Acquisition in 2017 
Klaxcar France S.A., founded in 1993 and headquartered in Dourdan, France, specializes in the design and manufacture of automotive spare parts for the aftermarket sector. The company provides Original Part quality products at competitive prices, offering a diverse range of components including lamps, wiper blades, glow and spark plugs, horns, belts, water pumps, and brake discs. By supplying a comprehensive selection of spare parts from a single source, Klaxcar aims to meet the needs of the automobile sector effectively.
Medlumics
Series B in 2017 
Founded in 2009, Medlumics designs and manufactures catheter-based systems for treating supraventricular tachycardias. Utilizing optical coherence tomography technology, the company's products provide real-time, sectional information about tissue, enhancing procedural safety and efficacy.
NetCo
Venture Round in 2016 
Groupe NetCo specializes in the design, manufacture, assembly, maintenance, and installation of conveyor systems, including both belt and roller types. The company offers a diverse range of conveyor belts made from rubber and various polymers, along with specialized accessories such as wipers, rollers, and drive pulleys. NetCo also provides services like on-site installation, training for conveyor belt operation, and custom transformations of conveyor belts. Serving a wide array of industries, including waste management, logistics, agrifood, pharmaceuticals, and energy sectors, the company has established itself as a leader in the domestic market within a decade of operation. Founded in 1902 and based in Bordeaux, France, Groupe NetCo was previously known as PERRIEZ and rebranded in 1999.
The Reefer Group
Private Equity Round in 2016 
The Reefer Group SL is a company based in Alzira, Spain, specializing in the design and manufacture of refrigerated vehicles, including semi-trailers and trucks, for temperature-controlled transportation. Established in 2015, it serves both domestic and international markets by offering a range of products such as new and used refrigerated semi-trailers, tractor-trailers, removable bodies, and utility vehicles tailored for the transport of perishable goods like meat, dairy, fruits, vegetables, flowers, and pharmaceuticals. In addition to its manufacturing capabilities, The Reefer Group provides spare parts, servicing and repairs, rebuilding services, liveries, rentals, after-sales training, vehicle upgrades, and special equipment. The company also has a sales network for distributing its products and second-hand vehicles.
MS Vacances
Venture Round in 2016 
MS Vacances SAS, established in 1992 and located in Nantes, France, specializes in the hospitality sector by providing boarding and lodging services. The company operates holiday homes across France and offers a range of mobile leisure accommodations, incorporating amenities such as camping facilities, indoor pools, bars, restaurants, grocery services, and laundry facilities. Additionally, MS Vacances is known for its premium air travel services in the Atlantic and Mediterranean regions, enhancing the overall holiday experience for its customers.
Mondial Pet Distribution
Venture Round in 2016 
Mondial Pet Distribution S.p.A. is an Italian company based in Fossano that specializes in the distribution of hygiene and personal products for animals, operating under the Fortesan brand. The company focuses on providing quality products designed to meet the needs of pet care. As of April 2018, Mondial Pet Distribution operates as a subsidiary of Agrifarma S.p.A.
Orchestra
Acquisition in 2016 
Orchestra is an online platform dedicated to the travel industry. It enables professionals to produce, administrate, distribute, and manage leisure offers on many distribution channels.
Orchestra is based in Lopera, Spain.
Ipside
Venture Round in 2016 
Ipside is a firm that specializes in providing industrial property attorney services, focusing on the protection and management of intellectual property rights for clients in various sectors, including telecommunications, software, aerospace, pharmaceuticals, biotechnology, and optoelectronics. The company assists clients in obtaining, operating, and defending their patents internationally, while also exploring additional methods to protect technical inventions. Ipside offers comprehensive litigation and consultancy services covering patent law, trademark law, design law, copyright law, and software rights. Through its expertise, the firm develops tailored strategies that address the legal and technical aspects of commercialization, enabling clients to effectively navigate the complexities of their intellectual property and ensure robust protection for their innovative solutions.
Sogetrel
Private Equity Round in 2016 
Sogetrel, S.A.S. is a prominent company specializing in the design, deployment, and maintenance of network infrastructures and digital communication solutions. Established in 1985 and headquartered in Issy les Moulineaux, France, Sogetrel operates branches in Belgium and Switzerland. The company provides a range of services, including the integration of telecommunications networks, IP security systems for video surveillance and access control, and support for smart city projects. Sogetrel serves a diverse clientele across various sectors such as telecommunications, public authorities, defense, transport, and utilities. By focusing on the development of very high-speed networks and offering both customized and turnkey solutions, Sogetrel aims to enhance the quality of life for citizens while promoting efficiency and sustainability in the regions it serves.
REALEASE Capital
Private Equity Round in 2015 
REALEASE Capital is a French company based in Puteaux that provides leasing and financing solutions for manufacturers of materials used in videoconferencing and other technological assets. Founded in 1986, the company specializes in the progressive rental of a diverse range of equipment, including IT, telecom, industrial, audiovisual, medical, and digital devices. Through its financial services, REALEASE Capital aims to support businesses in acquiring essential technology without the burdens of outright purchase, thereby facilitating access to innovative tools across various sectors.
Groupe ERGET
Venture Round in 2015 
Groupe ERGET SA is a French company specializing in surveying and loss adjustment, founded in 1986 and headquartered in Neuilly-sur-Seine, France. The company provides expertise in various sectors, including construction, aviation, energy, industry, safety, fire protection, and product liability, serving a diverse clientele that includes insurers, brokers, industrialists, and legal professionals. With a workforce of 120 employees, including 85 multidisciplinary surveyors, Groupe ERGET has expanded its international presence since 2006, operating in regions such as Asia, South America, and the West Indies, along with establishing a joint venture across over 30 African countries. The company has completed more than 5,500 missions in 115 countries, generating a turnover of 20 million euros, with 35% of its revenue derived from international operations. Through its strategic acquisitions and growth initiatives, Groupe ERGET aims to solidify its position as a leader in the francophone market and continue expanding into emerging markets.
ACE Group
Venture Round in 2015 
ACE Group is a prominent French mortgage broker specializing in credit brokerage for real estate assets. The company provides a range of services aimed at facilitating mortgage solutions for individuals and businesses seeking to finance property purchases. With a focus on understanding client needs and market conditions, ACE Group aims to deliver tailored financial solutions that support clients in navigating the complexities of real estate financing. By leveraging industry expertise and market insights, ACE Group positions itself as a key player in the mortgage brokerage sector in France.
ACE Group
Private Equity Round in 2015 
ACE Group is a prominent French mortgage broker specializing in credit brokerage for real estate assets. The company provides a range of services aimed at facilitating mortgage solutions for individuals and businesses seeking to finance property purchases. With a focus on understanding client needs and market conditions, ACE Group aims to deliver tailored financial solutions that support clients in navigating the complexities of real estate financing. By leveraging industry expertise and market insights, ACE Group positions itself as a key player in the mortgage brokerage sector in France.
Emeraude International
Private Equity Round in 2014 
Founded in 1986, Emeraude International is a global distributor of polymers and chemicals. It offers a wide range of polyolefins and thermoplastics for various applications such as packaging films, bottles, pipes, fibers, and injection molding. The company also provides chemicals and additives for diverse industries like food, paint, agriculture, water treatment, personal care, and foam production. Emeraude International serves customers primarily in Africa, the Indian subcontinent, Europe, and Southeast Asia.
A2iA
Private Equity Round in 2014 
A2iA S.A. is a developer of advanced software solutions focused on handwritten and machine-printed text recognition, information extraction, and intelligent document classification. The company offers various toolkits, including a2ia Mobility, which supports multiple workflows for document processing; a2ia mNote, which digitizes handwritten notes directly on mobile devices; and a2ia DocumentReader, designed for data extraction from diverse document types. Additional products include a2ia TextReader for transcribing printed and cursive text, a2ia CheckReader for secure data capture from payment documents, and a2ia FieldReader for extracting information from forms. A2iA serves a wide range of industries, including banking, fintech, telecommunications, healthcare, insurance, and government, with a global presence across Europe, North America, Latin America, the Middle East, Africa, India, and the Asia Pacific. Founded in 1991 and headquartered in Paris, France, with an office in New York, A2iA operates as a subsidiary of Mitek Systems, Inc.
Maesa
Venture Round in 2014 
Maesa is a company based in Levallois Perret, France, specializing in the design and manufacture of tailor-made perfumes, cosmetics, and promotional products. Founded in 1997, it operates across Europe, Asia, and North America. Maesa focuses on various aspects of product development, including brand identity, industrial design, package design, and graphic design. The company offers turnkey beauty products and home fragrance solutions for retailers and brands, and it also provides packaging components and promotional products for the beauty industry. In addition to its manufacturing capabilities, Maesa serves as a beauty brand incubator, creating exclusive brands and private labels for a range of retail sectors, including mass, drug, and specialty markets.
Thomson Video Networks
Private Equity Round in 2014 
Thomson Video Networks SAS specializes in providing comprehensive video delivery solutions for broadcasters globally. The company offers a range of services, including satellite direct-to-home, digital terrestrial television, IPTV, web TV, and mobile TV solutions. Its product lineup features video compression systems such as HD and SD encoders, multiscreen video systems, and contribution codec platforms, alongside processing and multiplexing systems including MPEG multiplexers and video processors. Additionally, Thomson Video Networks provides advanced decoding systems, data casting solutions, and monitoring and switching systems to ensure efficient video signal management. The company also supports its clients with integration, consultancy, technical support, and training services. Established in 2010 and headquartered in Cesson-Sevigne, France, Thomson Video Networks operates as a subsidiary of Harmonic Inc.
Poxel is a biopharmaceutical company based in Lyon, France, focused on developing innovative drugs for metabolic diseases, with a primary emphasis on type 2 diabetes and non-alcoholic steatohepatitis (NASH). Founded in 2009, Poxel's lead product is Imeglimin, an oral anti-diabetic candidate in Phase III clinical development that targets key organs affected by diabetes, such as the pancreas, liver, and muscles. The company is also advancing PXL770, an adenosine monophosphate-activated protein kinase enzyme in Phase IIa clinical trials for treating chronic metabolic diseases like NASH. Additionally, Poxel has licensing agreements for PXL007 (EYP001), an FXR agonist in Phase I study for hepatitis B and NASH, and PXL065, a mitochondrial pyruvate carrier inhibitor in Phase I clinical trials for NASH.
Groupe ADF
Private Equity Round in 2014 
Groupe ADF SAS is an industrial maintenance and engineering services provider based in Vitrolles, France, founded in 1962. The company specializes in delivering maintenance solutions across various sectors, including aeronautics, space and defense, energy, and oil and gas. Its offerings encompass a wide range of services such as maintenance for the petrochemical and metallurgical industries, naval and port repairs, and pharmaceutical and agro-food sectors. Additionally, Groupe ADF provides turn-key solutions, revamping work, management of statutory stoppage work, and environmental services like waste management and industrial cleaning. The company is also involved in equipment integration and digital transformation to enhance production support and automate business processes.
Genticel is a French clinical-stage biotechnology company established in 2001 by Benedikt Timmerman. The company specializes in developing innovative immunotherapies aimed at treating viral infections and diseases associated with viruses, particularly focusing on human papillomavirus (HPV) and HPV-related conditions, such as cervical cancer. Genticel's product offerings include its proprietary technological platform, Vaxiclase, along with specific immunotherapy candidates GTL001 and GTL002. By concentrating on HPV and its implications, Genticel aspires to emerge as a leader in the field of immunotherapy across various medical indications.
ITESA
Private Equity Round in 2013 
ITESA, established in Marseille, France since 1978, is an independent distributor specializing in security systems for professional clients. The company offers a comprehensive range of products including alarm panels, detection systems, barriers, signaling devices, transmission equipment, power supplies, cables, batteries, accessories, management products, biometric identification tools, video surveillance products, intercom systems, automation solutions, audio-visual equipment, and fire safety gear. ITESA sells these products primarily through agencies in France and Switzerland, focusing on providing innovative, high-quality items along with expert advice and services to help its partners excel in their field.
Poxel is a biopharmaceutical company based in Lyon, France, focused on developing innovative drugs for metabolic diseases, with a primary emphasis on type 2 diabetes and non-alcoholic steatohepatitis (NASH). Founded in 2009, Poxel's lead product is Imeglimin, an oral anti-diabetic candidate in Phase III clinical development that targets key organs affected by diabetes, such as the pancreas, liver, and muscles. The company is also advancing PXL770, an adenosine monophosphate-activated protein kinase enzyme in Phase IIa clinical trials for treating chronic metabolic diseases like NASH. Additionally, Poxel has licensing agreements for PXL007 (EYP001), an FXR agonist in Phase I study for hepatitis B and NASH, and PXL065, a mitochondrial pyruvate carrier inhibitor in Phase I clinical trials for NASH.
Novamex SA
Private Equity Round in 2011 
Novamex S.A. produces natural and eco-friendly cleaning, washing, and personal hygiene products to individuals and companies in France. It offers washing powders and liquids, cleaning liquids, shampoos, moisturizers, and hair conditioning products.
SuperSonic Imagine
Series C in 2010 
SuperSonic Imagine SA is a medical technology company based in Aix-en-Provence, France, specializing in the development and manufacture of ultrasound imaging systems. Founded in 2005, the company is recognized for its Aixplorer system, which delivers high-definition, high-contrast imaging crucial for diagnosing and monitoring various conditions, including breast, prostate, and thyroid cancers, as well as liver diseases. SuperSonic Imagine also offers the ShearWave technology platform, which focuses on quantitative elastography for assessing tissue elasticity. The company operates primarily in France, the United States, and China, and distributes its products through a network of offices and partners across various countries, including Belgium, Germany, and the United Kingdom. As a subsidiary of Hologic Hub Ltd, SuperSonic Imagine continues to innovate in the field of medical imaging technology, enhancing the capabilities of healthcare practitioners.
Garden Price
Venture Round in 2010 
Garden Price is a Les Nouvelles Jardineries, a Maurepas, France-based chain of low-cost garden stores.
Founded in 2006, Implanet designs, manufactures, and sells high-quality orthopedic implants for surgical markets worldwide. Its product portfolio includes spinal fixation systems like Jazz, knee prostheses such as Madison, and other orthopedic devices.
Poxel is a biopharmaceutical company based in Lyon, France, focused on developing innovative drugs for metabolic diseases, with a primary emphasis on type 2 diabetes and non-alcoholic steatohepatitis (NASH). Founded in 2009, Poxel's lead product is Imeglimin, an oral anti-diabetic candidate in Phase III clinical development that targets key organs affected by diabetes, such as the pancreas, liver, and muscles. The company is also advancing PXL770, an adenosine monophosphate-activated protein kinase enzyme in Phase IIa clinical trials for treating chronic metabolic diseases like NASH. Additionally, Poxel has licensing agreements for PXL007 (EYP001), an FXR agonist in Phase I study for hepatitis B and NASH, and PXL065, a mitochondrial pyruvate carrier inhibitor in Phase I clinical trials for NASH.
Founded in 2006, Implanet designs, manufactures, and sells high-quality orthopedic implants for surgical markets worldwide. Its product portfolio includes spinal fixation systems like Jazz, knee prostheses such as Madison, and other orthopedic devices.
Genticel is a French clinical-stage biotechnology company established in 2001 by Benedikt Timmerman. The company specializes in developing innovative immunotherapies aimed at treating viral infections and diseases associated with viruses, particularly focusing on human papillomavirus (HPV) and HPV-related conditions, such as cervical cancer. Genticel's product offerings include its proprietary technological platform, Vaxiclase, along with specific immunotherapy candidates GTL001 and GTL002. By concentrating on HPV and its implications, Genticel aspires to emerge as a leader in the field of immunotherapy across various medical indications.
Smile
Venture Round in 2010 
Smile specializes in integrating open-source solutions for businesses. Based in Levallois-Perret, France, they offer services in digital evolution, embedded technologies, IoT, infrastructure management, and business applications.
Founded in 2006, Implanet designs, manufactures, and sells high-quality orthopedic implants for surgical markets worldwide. Its product portfolio includes spinal fixation systems like Jazz, knee prostheses such as Madison, and other orthopedic devices.
SuperSonic Imagine
Series B in 2008 
SuperSonic Imagine SA is a medical technology company based in Aix-en-Provence, France, specializing in the development and manufacture of ultrasound imaging systems. Founded in 2005, the company is recognized for its Aixplorer system, which delivers high-definition, high-contrast imaging crucial for diagnosing and monitoring various conditions, including breast, prostate, and thyroid cancers, as well as liver diseases. SuperSonic Imagine also offers the ShearWave technology platform, which focuses on quantitative elastography for assessing tissue elasticity. The company operates primarily in France, the United States, and China, and distributes its products through a network of offices and partners across various countries, including Belgium, Germany, and the United Kingdom. As a subsidiary of Hologic Hub Ltd, SuperSonic Imagine continues to innovate in the field of medical imaging technology, enhancing the capabilities of healthcare practitioners.
EOS Imaging
Venture Round in 2007 
EOS Imaging SA is a medical technology company based in Paris, France, specializing in low-dose 2D/3D imaging and software solutions for osteo-articular conditions and orthopedic surgeries. The company develops and markets the EOS imaging system, which produces full-body, stereo-radiographic images of patients in functional positions, tailored to the specific needs of orthopedic surgeons and radiologists. Its product offerings include EOSedge, a high-quality X-ray system, sterEOS, a 3D modeling workstation for precise skeletal analysis, and EOSapps, online surgical planning solutions based on real-time imaging. Additionally, EOS Imaging creates planning software for knee and hip surgeries and manufactures patient-specific cutting guides for orthopedic procedures. The company operates globally, with a presence in Europe, the Middle East, Africa, North America, the Asia-Pacific, and Latin America, and has obtained marketing authorization for its systems in 48 countries. Founded in 1989, EOS Imaging was previously known as biospace med before rebranding in 2010.
Founded in 2006, Implanet designs, manufactures, and sells high-quality orthopedic implants for surgical markets worldwide. Its product portfolio includes spinal fixation systems like Jazz, knee prostheses such as Madison, and other orthopedic devices.
Domain Therapeutics
Series C in 2006 
Domain Therapeutics SA is a biopharmaceutical company based in Illkirch-Graffenstaden, France, focused on the discovery and early development of therapeutic drugs targeting G protein-coupled receptors (GPCRs), which are key drug targets in various diseases. Founded in 2001, the company specializes in developing small molecules for the treatment of central nervous system (CNS) disorders and cancer. It employs its proprietary technology platform, DTect-All, which enables the identification of orthosteric and allosteric ligands, including Silent Allosteric Modulators (SAMs) that are challenging to discover using conventional methods. In addition, Domain Therapeutics offers BioSens-All, a platform to explore the signaling complexities associated with GPCR activation, enhancing its ability to address difficult targets, such as orphan and peptidic GPCRs.
Cytomics Pharmaceuticals
Series B in 2006 
Cytomics Systems is a French private company that offers bio-pharmacology services. The company uses Yeast Micro-Lab technology, a protenomics tool, which enables to follow in-vitro deterioration of proteins. Cytomics Systems's research and development focuses on fungicidal infections, inflammatory illnesses, and cancers. Cytomics Systems, S.A was founded in 2000 and is based in Gif-sur-Yvette, France.
Cellectis
Series C in 2005 
Cellectis is a clinical-stage biotechnology company specializing in immuno-oncology. It develops allogeneic T-cell therapies using gene-editing technologies, focusing on chimeric antigen receptor (CAR) T-cells targeting various cancers.
Nautilus Biotech
Venture Round in 2005 
Nautilus Biotech is a biotechnology company. The company has a pipeline of therapeutic proteins with improved profiles. The company's products include Belerofon, an injectable and orally available interferon alpha for use in the treatment of chronic Hepatitis C infection; and Vitatropin, an injectable and orally available human growth hormone (hGH) for use in the treatment of growth deficiencies. Nautilus Biotech S.A. sells therapeutic proteins, including interferons, hormones, growth factors, and enzymes in France and internationally. The company's protein engineering technology improves the pharmacology profile and administration route of blockbuster protein drugs. Nautilus Biotech S.A. was founded in 1999 and is based in Evry, France.
Domain Therapeutics
Series B in 2004 
Domain Therapeutics SA is a biopharmaceutical company based in Illkirch-Graffenstaden, France, focused on the discovery and early development of therapeutic drugs targeting G protein-coupled receptors (GPCRs), which are key drug targets in various diseases. Founded in 2001, the company specializes in developing small molecules for the treatment of central nervous system (CNS) disorders and cancer. It employs its proprietary technology platform, DTect-All, which enables the identification of orthosteric and allosteric ligands, including Silent Allosteric Modulators (SAMs) that are challenging to discover using conventional methods. In addition, Domain Therapeutics offers BioSens-All, a platform to explore the signaling complexities associated with GPCR activation, enhancing its ability to address difficult targets, such as orphan and peptidic GPCRs.
Cellectis
Series B in 2002 
Cellectis is a clinical-stage biotechnology company specializing in immuno-oncology. It develops allogeneic T-cell therapies using gene-editing technologies, focusing on chimeric antigen receptor (CAR) T-cells targeting various cancers.